Showing results (441-450 of 763) with videos related to
Sort By:
Pageof 77
Journal of Hypertension|October 8, 2009
Antihypertensive effects of double the maximum dose of valsartan in African-American patients with type 2 diabetes mellitus and albuminuriaMatthew R Weir, Norman K Hollenberg, Dion H Zappe, et al.Plos One|August 23, 2013
Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitorCristina Zanchi, Monica Locatelli, Ariela Benigni, et al.The American Journal of Pathology|July 2, 2011
Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architectureAriela Benigni, Marina Morigi, Paola Rizzo, et al.Plos One|May 21, 2015
Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin IIDaniela Macconi, Luca Perico, Lorena Longaretti, et al.Journal of the American Society of Nephrology : JASN|November 22, 2002
How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approachCarla Zoja, Daniela Corna, Davide Camozzi, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 2017
BRAF Signaling Pathway Inhibition, Podocyte Injury, and Nephrotic SyndromeLuca Perico, Mario Mandalà, Arrigo Schieppati, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 10, 2017
Long-term outcome of renal transplantation from octogenarian donors: A multicenter controlled studyPiero Ruggenenti, Cristina Silvestre, Luigino Boschiero, et al.Plos One|May 31, 2017
Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney diseaseKanishka Sharma, Anna Caroli, Le Van Quach, et al.American Journal of Nephrology|January 24, 2015
Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational studyGiorgio Gentile, Chiara Somma, Alessia Gennarini, et al.Journal of the American Society of Nephrology : JASN|July 24, 2012
Rituximab in idiopathic membranous nephropathyPiero Ruggenenti, Paolo Cravedi, Antonietta Chianca, et al.Pageof 77